By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


GenomeDx Biosciences 

400 – 311 Water Street

Vancouver  British Columbia  BC V6B 1B8  Canada
Phone: 1-888-975-4540 Fax: n/a



Company News
GenomeDx Biosciences Announces Initiation By Michigan Urological Surgery Improvement Collaborative 3/2/2017 8:02:29 AM
GenomeDx Biosciences Announces Research Collaboration With Astellas (ALPMY) To Identify Genomic Drivers Of Patient Response To XTANDI (Enzalutamide) Capsules 2/1/2017 8:38:16 AM
GenomeDx Biosciences Release: Diagnostic Company's Decipher Biopsy Demonstrates Ability To Predict Metastasis After Radiation And Androgen Deprivation Therapy In Prostate Cancer Patients 1/25/2017 9:55:04 AM
GenomeDx Biosciences's Decipher GRID Aids In Development And Validation Of The First Molecular Signature To Predict Response To Radiotherapy In Prostate Cancer 10/19/2016 9:17:15 AM
GenomeDx Biosciences And Bostwick Laboratories Announce Marketing Agreement For Decipher Prostate Cancer Classifier Test 10/4/2016 6:55:42 AM
GenomeDx Biosciences Launches Expanded GRID Tumor Profiling To Provide Enhanced Genomic Understanding Of Patients' Prostate Cancer 9/29/2016 10:19:39 AM
GenomeDx Biosciences And SouthGenetics Announce Strategic Agreement For Latin America Commercialization 9/28/2016 6:49:22 AM
GenomeDx Biosciences's Decipher GRID And Decipher Tests To Be Featured In Multiple Presentations At ASTRO 2016 9/22/2016 10:37:25 AM
GenomeDx Biosciences Adds Multiple Leading Cancer Centers To Its Proprietary Genomics Resource Information Database Platform (Decipher GRID) 9/13/2016 10:46:59 AM
Prospective Study Shows GenomeDx Biosciences's Decipher Cancer Classifier Significantly Reclassifies Tumor Aggressiveness 9/6/2016 8:07:44 AM